Related Experiment Video
Updated: Aug 10, 2026
09:00
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
A receptor-based bioassay for quantitative detection of gallium
1Department of Chemistry, State University of New York at Binghamton 13902, USA.
Analytical Chemistry
|December 22, 1999
Summary
New protein conjugates enable sensitive and selective detection of gallium in biological samples for tumor diagnosis and treatment monitoring. This non-antibody assay offers accurate gallium quantification in clinical toxicology and animal physiology studies.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Toxicology
Background:
- Gallium detection in biological samples is crucial for tumor diagnosis and malignancy treatment.
- Existing instrumental techniques are inadequate for detecting low gallium levels in complex biological matrices.
Purpose of the Study:
- To develop a novel, sensitive, and selective method for gallium detection in biological samples.
- To create protein conjugates for a non-antibody-based sandwich assay for gallium quantification.
Main Methods:
- Synthesis of new protein conjugates utilizing 4-(2-pyridylazo) ligands.
- Application of these conjugates in a non-antibody-based sandwich assay format.
- Validation of the assay for recovery, precision, detection limit, and selectivity.
Main Results:
- Achieved recovery levels between 97% and 101.3% with a relative standard deviation below 5%.
- Established a detection limit of 5 x 10(-8) M for gallium(III).
- Demonstrated remarkable selectivity for gallium(III) over other investigated metal ions.
Conclusions:
- The developed protein conjugate-based assay is suitable for accurate gallium detection in biological samples.
- This method is applicable for animal physiology studies and clinical toxicology.
- The assay overcomes limitations of purely instrumental techniques for low-level gallium detection.
